{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:11:13Z","timestamp":1793319073305,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Swedish Heart Lung foundation"},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010819","name":"Stiftelsen Tornspiran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"M\u00e4rta and Gunnar V Philipson Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-017-0562-x","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T14:31:55Z","timestamp":1495031515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["AT1-receptor response to non-saturating Ang-II concentrations is amplified by calcium channel blockers"],"prefix":"10.1186","volume":"17","author":[{"given":"Kristoffer","family":"Bernhem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalaiselvan","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bondar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hjalmar","family":"Brismar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Aperia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,17]]},"reference":[{"issue":"1","key":"562_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(24)01478-9","volume":"53","author":"SSG Ferguson","year":"2001","unstructured":"Ferguson SSG. Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling. Pharmacol Rev. 2001;53(1):1\u201324.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"562_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.cr.7290083","volume":"11","author":"DF Guo","year":"2001","unstructured":"Guo DF, et al. The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res. 2001;11(3):165\u201380.","journal-title":"Cell Res"},{"issue":"12","key":"562_CR3","first-page":"2040","volume":"14","author":"PH Anborg","year":"2000","unstructured":"Anborg PH, Seachrist JL, Dale LB, Ferguson SS. Receptor\/\u03b2-Arrestin Complex Formation and the Differential Trafficking and Resensitization of\u03b2 2-Adrenergic and Angiotensin II Type 1A Receptors. Mol Endocrinol. 2000;14(12):2040\u201353.","journal-title":"Mol Endocrinol"},{"issue":"3","key":"562_CR4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.111.00377","volume":"61","author":"AC Arnold","year":"2013","unstructured":"Arnold AC, et al. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension. 2013;61(3):701\u20136.","journal-title":"Hypertension"},{"issue":"5647","key":"562_CR5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/bmj.1.5647.819","volume":"1","author":"KJ Catt","year":"1969","unstructured":"Catt KJ, et al. Blood angiotensin II levels of normal and hypertensive subjects. Br Med J. 1969;1(5647):819\u201321.","journal-title":"Br Med J"},{"issue":"3","key":"562_CR6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/mol.59.3.576","volume":"59","author":"A Garcia-Caballero","year":"2001","unstructured":"Garcia-Caballero A, et al. Angiotensin AT(1) receptor phosphorylation and desensitization in a hepatic cell line. Roles of protein kinase c and phosphoinositide 3-kinase. Mol Pharmacol. 2001;59(3):576\u201385.","journal-title":"Mol Pharmacol"},{"key":"562_CR7","unstructured":"Dasgupta, K., et al., The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol 30(5): p. 485-501."},{"issue":"8","key":"562_CR8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/CIRCRESAHA.110.217018","volume":"107","author":"GC Amberg","year":"2010","unstructured":"Amberg GC, Earley S, Glapa SA. Local regulation of arterial L-type calcium channels by reactive oxygen species. Circ Res. 2010;107(8):1002\u201310.","journal-title":"Circ Res"},{"issue":"3","key":"562_CR9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.HYP.0000139914.52686.74","volume":"44","author":"WC De Mello","year":"2004","unstructured":"De Mello WC, Monterrubio J. Intracellular and Extracellular Angiotensin II Enhance the L-Type Calcium Current in the Failing Heart. Hypertension. 2004;44(3):360\u20134.","journal-title":"Hypertension"},{"issue":"35","key":"562_CR10","doi-asserted-by":"crossref","first-page":"32545","DOI":"10.1074\/jbc.M102582200","volume":"276","author":"J-F Quignard","year":"2001","unstructured":"Quignard J-F, et al. Phosphoinositide 3-Kinase \u03b3 Mediates Angiotensin II-induced Stimulation of L-type Calcium Channels in Vascular Myocytes. J Biol Chem. 2001;276(35):32545\u201351.","journal-title":"J Biol Chem"},{"issue":"8","key":"562_CR11","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1523\/JNEUROSCI.3251-06.2007","volume":"27","author":"MJ Beckstead","year":"2007","unstructured":"Beckstead MJ, Williams JT. Long-Term Depression of a Dopamine IPSC. J Neurosci. 2007;27(8):2074\u201380.","journal-title":"J Neurosci"},{"issue":"5","key":"562_CR12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/npp.2010.237","volume":"36","author":"S Perra","year":"2011","unstructured":"Perra S, et al. In Vivo Ethanol Experience Increases D2 Autoinhibition in the Ventral Tegmental Area. Neuropsychopharmacology. 2011;36(5):993\u20131002.","journal-title":"Neuropsychopharmacology"},{"key":"562_CR13","doi-asserted-by":"crossref","first-page":"e09358","DOI":"10.7554\/eLife.09358","volume":"4","author":"SC Gantz","year":"2015","unstructured":"Gantz SC, et al. Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium. elife. 2015;4:e09358.","journal-title":"elife"},{"key":"562_CR14","first-page":"279","volume-title":"Technique","author":"GL Engelmann","year":"1990","unstructured":"Engelmann GL, et al. Serum free primary cultures of neonatal rat cardiomyocytes cellular and molecular applications. In: Technique, vol. 2; 1990. p. 279\u201391."},{"issue":"3","key":"562_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2011040344","volume":"23","author":"D Li","year":"2012","unstructured":"Li D, et al. Binding of losartan to angiotensin AT1 receptors increases dopamine D1 receptor activation. J Am Soc Nephrol. 2012;23(3):421\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"562_CR16","doi-asserted-by":"crossref","first-page":"e0146789","DOI":"10.1371\/journal.pone.0146789","volume":"11","author":"J Unen van","year":"2016","unstructured":"van Unen J, et al. A New Generation of FRET Sensors for Robust Measurement of G\u03b1i1, G\u03b1i2 and G\u03b1i3 Activation Kinetics in Single Cells. PLoS One. 2016;11(1):e0146789.","journal-title":"PLoS One"},{"issue":"11","key":"562_CR17","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1210\/endo.142.11.8485","volume":"142","author":"A Hus-Citharel","year":"2001","unstructured":"Hus-Citharel A, et al. Desensitization of Type 1 Angiotensin II Receptor Subtypes in the Rat Kidney. Endocrinology. 2001;142(11):4683\u201392.","journal-title":"Endocrinology"},{"issue":"1","key":"562_CR18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1074\/jbc.M112.392514","volume":"288","author":"H Unal","year":"2013","unstructured":"Unal H, et al. Long range effect of mutations on specific conformational changes in the extracellular loop 2 of angiotensin II type 1 receptor. J Biol Chem. 2013;288(1):540\u201351.","journal-title":"J Biol Chem"},{"issue":"2","key":"562_CR19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/HYPERTENSIONAHA.109.145839","volume":"55","author":"CM Ferrario","year":"2010","unstructured":"Ferrario CM. New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism. Hypertension. 2010;55(2):445\u201352.","journal-title":"Hypertension"},{"issue":"3","key":"562_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","volume":"59","author":"H Kobori","year":"2007","unstructured":"Kobori H, et al. The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease. Pharmacol Rev. 2007;59(3):251\u201387.","journal-title":"Pharmacol Rev"},{"issue":"9","key":"562_CR21","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/01.ASN.0000026610.48842.CB","volume":"13","author":"A Nishiyama","year":"2002","unstructured":"Nishiyama A, Seth DM, Navar LG. Renal Interstitial Fluid Angiotensin I and Angiotensin II Concentrations during Local Angiotensin-Converting Enzyme Inhibition. J Am Soc Nephrol. 2002;13(9):2207\u201312.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"562_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2007.01.016","volume":"74","author":"DJ Triggle","year":"2007","unstructured":"Triggle DJ. Calcium channel antagonists: Clinical uses\u2014Past, present and future. Biochem Pharmacol. 2007;74(1):1\u20139.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"562_CR23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4161\/chan.21708","volume":"6","author":"NL Chaplin","year":"2012","unstructured":"Chaplin NL, Amberg GC. Stimulation of arterial smooth muscle L-type calcium channels by hydrogen peroxide requires protein kinase C. Channels. 2012;6(5):385\u20139.","journal-title":"Channels"},{"issue":"43","key":"562_CR24","first-page":"12","volume":"7","author":"GW Zamponi","year":"2013","unstructured":"Zamponi GW, Currie KP. Regulation of Ca(V)2 calcium channels by G protein coupled receptors. Biochim Biophys Acta. 2013;7(43):12.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"562_CR25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/j.1552-4604.1985.tb02812.x","volume":"25","author":"M Traube","year":"1985","unstructured":"Traube M, et al. Correlation of Plasma Levels of Nifedipine and Cardiovascular Effects After Sublingual Dosing in Normal Subjects. J Clin Pharmacol. 1985;25(2):125\u20139.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"562_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/15563650500514541","volume":"44","author":"J Wilimowska","year":"2006","unstructured":"Wilimowska J, et al. Monitoring of Verapamil Enantiomers Concentration in Overdose. Clin Toxicol. 2006;44(2):169\u201371.","journal-title":"Clin Toxicol"},{"issue":"5","key":"562_CR27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1085\/jgp.201311050","volume":"143","author":"J Mercado","year":"2014","unstructured":"Mercado J, et al. Local control of TRPV4 channels by AKAP150-targeted PKC in arterial smooth muscle. The Journal of General Physiology. 2014;143(5):559\u201375.","journal-title":"The Journal of General Physiology"},{"issue":"12","key":"562_CR28","doi-asserted-by":"crossref","first-page":"10997","DOI":"10.1074\/jbc.M411797200","volume":"280","author":"L-P He","year":"2005","unstructured":"He L-P, et al. A Functional Link between Store-operated and TRPC Channels Revealed by the 3,5-Bis(trifluoromethyl)pyrazole Derivative, BTP2. J Biol Chem. 2005;280(12):10997\u20131006.","journal-title":"J Biol Chem"},{"issue":"4","key":"562_CR29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/mi.10.4.4","volume":"10","author":"JW Putney","year":"2010","unstructured":"Putney JW. Pharmacology of Store-operated Calcium Channels. Mol Interv. 2010;10(4):209\u201318.","journal-title":"Mol Interv"},{"issue":"6","key":"562_CR30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3122\/jabfm.2009.06.090094","volume":"22","author":"HT Ong","year":"2009","unstructured":"Ong HT. Are Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Especially Useful for Cardiovascular Protection? The Journal of the American Board of Family Medicine. 2009;22(6):686\u201397.","journal-title":"The Journal of the American Board of Family Medicine"},{"issue":"2","key":"562_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2010.1949","volume":"305","author":"M Eklind-Cervenka","year":"2011","unstructured":"Eklind-Cervenka M, et al. Association of candesartan vs losartan with all-cause mortality in patients with heart failure. JAMA. 2011;305(2):175\u201382.","journal-title":"JAMA"},{"issue":"1","key":"562_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","volume":"119","author":"I Splawski","year":"2004","unstructured":"Splawski I, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119(1):19\u201331.","journal-title":"Cell"},{"issue":"10","key":"562_CR33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0002-9149(88)91075-2","volume":"61","author":"S Betocchi","year":"1988","unstructured":"Betocchi S, et al. Relation between serum nifedipine concentration and hemodynamic effects in nonobstructive hypertrophic cardiomyopathy. Am J Cardiol. 1988;61(10):830\u20135.","journal-title":"Am J Cardiol"},{"issue":"1","key":"562_CR34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0378-4347(91)80221-W","volume":"570","author":"C K\u00f6ppel","year":"1991","unstructured":"K\u00f6ppel C, Wagemann A. Plasma level monitoring of d,l-verapamil and three of its metabolites by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1991;570(1):229\u201334.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"22","key":"562_CR35","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1074\/jbc.271.22.13266","volume":"271","author":"M Oppermann","year":"1996","unstructured":"Oppermann M, et al. Phosphorylation of the Type 1A Angiotensin II Receptor by G Protein-coupled Receptor Kinases and Protein Kinase C. J Biol Chem. 1996;271(22):13266\u201372.","journal-title":"J Biol Chem"},{"issue":"4","key":"562_CR36","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s11033-014-3043-7","volume":"41","author":"S Vedantam","year":"2014","unstructured":"Vedantam S, et al. Localization of angiotensin-II type 1(AT1) receptors on buffalo spermatozoa: AT1 receptor activation during capacitation triggers rise in cyclic AMP and calcium. Mol Biol Rep. 2014;41(4):1959\u201365.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"562_CR37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jash.2008.11.003","volume":"3","author":"MC Prieto-Carrasquero","year":"2009","unstructured":"Prieto-Carrasquero MC, et al. Collecting Duct Renin: A major player in Angiotensin II-dependent Hypertension. J Am Soc Hypertens. 2009;3(2):96\u2013104.","journal-title":"J Am Soc Hypertens"},{"issue":"3","key":"562_CR38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijcard.2005.02.016","volume":"106","author":"RM Wal van de","year":"2006","unstructured":"van de Wal RM, et al. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int J Cardiol. 2006;106(3):367\u201372.","journal-title":"Int J Cardiol"},{"issue":"3","key":"562_CR39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4161\/chan.5.3.15833","volume":"5","author":"T Hermosilla","year":"2011","unstructured":"Hermosilla T, et al. L-type calcium channel \u03b2 subunit modulates angiotensin II responses in cardiomyocytes. Channels. 2011;5(3):280\u20136.","journal-title":"Channels"},{"key":"562_CR40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/VHRM.S91020","volume":"12","author":"C Antza","year":"2016","unstructured":"Antza C, Stabouli S, Kotsis V. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence. Vasc Health Risk Manag. 2016;12:443\u201351.","journal-title":"Vasc Health Risk Manag"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T17:25:56Z","timestamp":1750267556000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0562-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,17]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0562-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,17]]},"article-number":"126"}}